2. Neurological Disease

Neurological Disease

Neurological Disease

Related Products

PDF 88.0 MB

A range of neurological disorders, including epilepsy and dystonia, may involve dysfunctional intracortical inhibition, and may respond to treatments that modify it. Parkinson’s is a neurodegenerative disease characterized by increased activity of GABA in basal ganglia and the loss of dopamine in nigrostriatum, associated with rigidity, resting tremor, gait with accelerating steps, and fixed inexpressive face. Neurological deficits, along with neuromuscular involvement, are characteristic of mitochondrial disease, and these symptoms can have a dramatic impact on patient quality of life. Neurological features may be manifold, ranging from neural deafness, ataxia, peripheral neuropathy, migraine, seizures, stroke‐like episodes and dementia and depend on the part of the nervous system affected.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-118490
    T-2000 97846-21-4 98%
    T-2000 (DMMDPB) is an orally active GABA receptor agonist with anticonvulsant activities.
    T-2000
  • HY-118502
    DOV51892 864673-91-6 98%
    DOV51892 is a GABAA receptor modulator. DOV51892 has a specific effect on GABAA receptors containing the α1 subunit. DOV51892 exhibits non-sedative anti-anxiety effects. DOV51892 can be used for in-depth research on the function of GABAA receptors.
    DOV51892
  • HY-118515
    ATM4 4-Acetoxy analog 91295-74-8 98%
    ATM4 4-Acetoxy analog is an impurity in the synthesis of Heroin.
    ATM4 4-Acetoxy analog
  • HY-118524
    Dipiproverine 117-30-6 98%
    Dipiproverine (LD-935 free base) is an alpha-amino acid ester, an antispasmodic compound, which is used as an anticholinergic agent.
    Dipiproverine
  • HY-118535
    N-Oleoyl valine 60374-41-6 98%
    N-Oleoyl valine is a N-acyl valine compound that acts as a TRPV3 receptor antagonist.
    N-Oleoyl valine
  • HY-118570
    5-Oxoprolyltryptophan 35937-24-7 98%
    5-Oxoprolyltryptophan is a model substrate for investigating the increase of serotonin at the cerebral level.
    5-Oxoprolyltryptophan
  • HY-118574
    UBP141 344768-30-5 98%
    UBP141 is a GluN2C/2D (NR2C/2D)-preferring receptor antagonist, with Kds of 2.8, 4.2, 14.2, and 19.3 μM for NMDA receptor subtypes: GluN2C, 2D, 2A, and 2B, respectively. UBP141 can induce potent motor impairment in WT mice.
    UBP141
  • HY-118575
    DR-4004 201608-41-5 98%
    DR-4004 is a 5-HT7 receptor antagonist that attenuates the decreased level of performance produced by mCPP and the performance levels after p-chloroamphetamine (PCA) lesion of the 5-HT system. DR-4004 also reverses amnesia induced by Scopolamine (HY-N0296) and Dizocilpine (HY-15084B). DR-4004 is promising for research of schizophrenia, cognitive deficits and atypical antipsychotic agents.
    DR-4004
  • HY-118615
    LY2048978 676495-11-7 98%
    LY2048978 is a non-selective opioid receptor antagonist with Ki of 0.287, 0.471 and 1.05 nM for human mu, kappa and delta opioid receptors in vitro, respectively. LY2048978 can be used in the research of major depressive disorder and alcohol use disorder.
    LY2048978
  • HY-118638
    Corynanthine 483-10-3 98%
    Corynanthine is a selective α1-adrenergic receptor antagonist. Corynanthine can significantly lower intraocular pressure in rabbits.
    Corynanthine
  • HY-118646
    NS-6740 753500-02-6 98%
    NS-6740 is an α7 nAChR agonist. NS-6740 can induce the desensitization state of α7 nAChRs. NS-6740 can result in the generation of robust nAChR-mediated currents. NS-6740 can be studied in neuronal-related research.
    NS-6740
  • HY-118656
    Cannabicitran 31508-71-1 98%
    Cannabicitran is a cannabinoid. Cannabicitran can decrease intraocular pressure in rabbits.
    Cannabicitran
  • HY-118657
    Ripazepam 26308-28-1 98%
    Ripazepam (Cl-683) is a potential antianxiety agent. Ripazepam also is a pyrazolodiazepinone derivative and has anxiolytic effects.
    Ripazepam
  • HY-118687
    4-BEC hydrochloride 135333-26-5 98%
    4-Bromoethcathinone hydrochloride is structurally categorized as a drug derivative.
    4-BEC hydrochloride
  • HY-118689
    RA-2 1867107-62-7 98%
    RA-2 is a negative-gating modulator of KCa2/3 channels with an IC50 of 17 nM. RA-2 inhibits bradykinin-induced endothelium-derived hyperpolarization (EDH)-type relaxation in U46619-precontracted rings. RA-2 can help to define the physiologic and pathomechanistic roles of KCa2/3 in the vasculature, central nervous system, and during inflammation.
    RA-2
  • HY-118710
    α-Isopropylaminopentiophenone hydrochloride 18268-14-9 99.98%
    α-Isopropylaminopentiophenone hydrochloride is a α-aminoketone derivative.
    α-Isopropylaminopentiophenone hydrochloride
  • HY-118727
    6-APDB hydrochloride 1281872-58-9 98%
    6-APDB hydrochloride is a benzofuran.
    6-APDB hydrochloride
  • HY-118768
    FMS586 free base 302556-51-0 98%
    FMS586 free base is a selective neuropeptide Y Y5 receptor antagonist with oral activity. FMS586 can completely block the significant increase in adrenocorticotropic hormone (ACTH) and cortisol caused by the Y(5) selective agonist hPP. FMS586 also reversed the significant upregulation of adrenocorticotropic hormone (CRF) and antidiuretic hormone (AVP) mRNA expression induced by central injection of hPP. FMS586 provides the first evidence that selective stimulation of Y(5) receptors triggers activation of the HPA axis.
    FMS586 free base
  • HY-118783
    2-Hexyl-4-pentynoic acid 96017-59-3 98.0%
    2-Hexyl-4-pentynoic acid ((±)-2-Hexyl-4-pentynoic acid), a Valproic acid (HY-10585) derivative, exhibits potential roles of HDAC inhibition (IC50 = 13 μM) and HSP70 induction. 2-Hexyl-4-pentynoic acid causes histone hyperacetylation and protect against glutamate-induced excitotoxicity in cultured neurons. 2-Hexyl-4-pentynoic acid can be used for the study of breast carcinoma. 2-Hexyl-4-pentynoic acid is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    2-Hexyl-4-pentynoic acid
  • HY-118806
    AC-42 244291-63-2 98%
    AC-42 is a poent M1 muscarinic selective allosteric agonist with EC50s of 805 nM and 220 nM for human wild-type and Y381A mutated M1 receptors, respectively. AC-42 stimulates the IP-accumulation and calcium mobilization in CHO cells.
    AC-42
Cat. No. Product Name / Synonyms Application Reactivity